Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Vimentin on the move: new developments in cell migration.

Battaglia RA, Delic S, Herrmann H, Snider NT.

F1000Res. 2018 Nov 15;7. pii: F1000 Faculty Rev-1796. doi: 10.12688/f1000research.15967.1. eCollection 2018. Review.

2.

The sweet side of vimentin.

Snider NT, Ku NO, Omary MB.

Elife. 2018 Mar 7;7. pii: e35336. doi: 10.7554/eLife.35336.

3.

An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells.

Trogden KP, Battaglia RA, Kabiraj P, Madden VJ, Herrmann H, Snider NT.

FASEB J. 2018 May;32(5):2841-2854. doi: 10.1096/fj.201700663R. Epub 2018 Jan 18.

PMID:
29401610
4.

Isolation of Intermediate Filament Proteins from Multiple Mouse Tissues to Study Aging-associated Post-translational Modifications.

Battaglia RA, Kabiraj P, Willcockson HH, Lian M, Snider NT.

J Vis Exp. 2017 May 18;(123). doi: 10.3791/55655.

5.

Ethanol and Acetaminophen Synergistically Induce Hepatic Aggregation and TCH346-Insensitive Nuclear Translocation of GAPDH.

Snider NT, Portney DA, Willcockson HH, Maitra D, Martin HC, Greenson JK, Omary MB.

PLoS One. 2016 Aug 11;11(8):e0160982. doi: 10.1371/journal.pone.0160982. eCollection 2016.

6.

Assay of Endocannabinoid Oxidation by Cytochrome P450.

Snider NT, Walker VJ, Hollenberg PF.

Methods Mol Biol. 2016;1412:227-36. doi: 10.1007/978-1-4939-3539-0_23.

PMID:
27245908
7.

Kidney keratins: cytoskeletal stress responders with biomarker potential.

Snider NT.

Kidney Int. 2016 Apr;89(4):738-40. doi: 10.1016/j.kint.2015.12.040.

PMID:
26994569
8.

Assays for Posttranslational Modifications of Intermediate Filament Proteins.

Snider NT, Omary MB.

Methods Enzymol. 2016;568:113-38. doi: 10.1016/bs.mie.2015.09.005. Epub 2015 Nov 6.

9.

PKC412 normalizes mutation-related keratin filament disruption and hepatic injury in mice by promoting keratin-myosin binding.

Kwan R, Chen L, Looi K, Tao GZ, Weerasinghe SV, Snider NT, Conti MA, Adelstein RS, Xie Q, Omary MB.

Hepatology. 2015 Dec;62(6):1858-69. doi: 10.1002/hep.27965. Epub 2015 Aug 25.

10.

Alternative splicing of human NT5E in cirrhosis and hepatocellular carcinoma produces a negative regulator of ecto-5'-nucleotidase (CD73).

Snider NT, Altshuler PJ, Wan S, Welling TH, Cavalcoli J, Omary MB.

Mol Biol Cell. 2014 Dec 15;25(25):4024-33. doi: 10.1091/mbc.E14-06-1167. Epub 2014 Oct 8.

11.

Modulation of cytoskeletal dynamics by mammalian nucleoside diphosphate kinase (NDPK) proteins.

Snider NT, Altshuler PJ, Omary MB.

Naunyn Schmiedebergs Arch Pharmacol. 2015 Feb;388(2):189-97. doi: 10.1007/s00210-014-1046-5. Epub 2014 Sep 20. Review.

12.

Post-translational modifications of intermediate filament proteins: mechanisms and functions.

Snider NT, Omary MB.

Nat Rev Mol Cell Biol. 2014 Mar;15(3):163-77. doi: 10.1038/nrm3753. Review.

13.

Reply: To PMID 23729294.

Snider NT, Omary MB.

Hepatology. 2014 Aug;60(2):767-8. doi: 10.1002/hep.26952. Epub 2014 Jun 18. No abstract available.

14.

A conserved rod domain phosphotyrosine that is targeted by the phosphatase PTP1B promotes keratin 8 protein insolubility and filament organization.

Snider NT, Park H, Omary MB.

J Biol Chem. 2013 Oct 25;288(43):31329-37. doi: 10.1074/jbc.M113.502724. Epub 2013 Sep 3.

15.

CD73 (ecto-5'-nucleotidase) hepatocyte levels differ across mouse strains and contribute to mallory-denk body formation.

Snider NT, Griggs NW, Singla A, Moons DS, Weerasinghe SV, Lok AS, Ruan C, Burant CF, Conjeevaram HS, Omary MB.

Hepatology. 2013 Nov;58(5):1790-800. doi: 10.1002/hep.26525. Epub 2013 Aug 26.

16.

Lamin aggregation is an early sensor of porphyria-induced liver injury.

Singla A, Griggs NW, Kwan R, Snider NT, Maitra D, Ernst SA, Herrmann H, Omary MB.

J Cell Sci. 2013 Jul 15;126(Pt 14):3105-12. doi: 10.1242/jcs.123026. Epub 2013 May 2.

17.

Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation.

Snider NT, Leonard JM, Kwan R, Griggs NW, Rui L, Omary MB.

J Cell Biol. 2013 Feb 4;200(3):241-7. doi: 10.1083/jcb.201209028. Epub 2013 Jan 28.

18.

Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria.

Singla A, Moons DS, Snider NT, Wagenmaker ER, Jayasundera VB, Omary MB.

Hepatology. 2012 Jul;56(1):322-31. doi: 10.1002/hep.25664. Epub 2012 Apr 25.

19.

Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation.

Snider NT, Weerasinghe SV, Singla A, Leonard JM, Hanada S, Andrews PC, Lok AS, Omary MB.

J Cell Biol. 2011 Oct 17;195(2):217-29. doi: 10.1083/jcb.201102142.

20.

Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.

Sridar C, Snider NT, Hollenberg PF.

Drug Metab Dispos. 2011 May;39(5):782-8. doi: 10.1124/dmd.110.036707. Epub 2011 Feb 2.

21.

Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed rat.

Hong S, Zheng G, Wu X, Snider NT, Owyang C, Wiley JW.

Gastroenterology. 2011 Feb;140(2):627-637.e4. doi: 10.1053/j.gastro.2010.11.003. Epub 2010 Nov 9.

22.

Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation.

Snider NT, Weerasinghe SV, Iñiguez-Lluhí JA, Herrmann H, Omary MB.

J Biol Chem. 2011 Jan 21;286(3):2273-84. doi: 10.1074/jbc.M110.171314. Epub 2010 Nov 9.

23.

Characterization of in vivo keratin 19 phosphorylation on tyrosine-391.

Zhou Q, Snider NT, Liao J, Li DH, Hong A, Ku NO, Cartwright CA, Omary MB.

PLoS One. 2010 Oct 25;5(10):e13538. doi: 10.1371/journal.pone.0013538.

24.

Effects of a commonly occurring genetic polymorphism of human CYP3A4 (I118V) on the metabolism of anandamide.

Pratt-Hyatt M, Zhang H, Snider NT, Hollenberg PF.

Drug Metab Dispos. 2010 Nov;38(11):2075-82. doi: 10.1124/dmd.110.033712. Epub 2010 Aug 11.

25.

Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.

Snider NT, Walker VJ, Hollenberg PF.

Pharmacol Rev. 2010 Mar;62(1):136-54. doi: 10.1124/pr.109.001081. Epub 2010 Feb 4. Review.

26.

Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.

Hanada S, Snider NT, Brunt EM, Hollenberg PF, Omary MB.

Gastroenterology. 2010 Apr;138(4):1607-17. doi: 10.1053/j.gastro.2009.12.055. Epub 2010 Jan 11.

27.

A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.

Snider NT, Nast JA, Tesmer LA, Hollenberg PF.

Mol Pharmacol. 2009 Apr;75(4):965-72. doi: 10.1124/mol.108.053439. Epub 2009 Jan 26.

28.

The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.

Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, Hollenberg PF.

J Pharmacol Exp Ther. 2008 Nov;327(2):538-45. doi: 10.1124/jpet.108.141796. Epub 2008 Aug 12.

29.

Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides.

Snider NT, Kornilov AM, Kent UM, Hollenberg PF.

J Pharmacol Exp Ther. 2007 May;321(2):590-7. Epub 2007 Feb 1.

PMID:
17272674
30.

Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

Rockwell CE, Snider NT, Thompson JT, Vanden Heuvel JP, Kaminski NE.

Mol Pharmacol. 2006 Jul;70(1):101-11. Epub 2006 Apr 12.

PMID:
16611855

Supplemental Content

Loading ...
Support Center